Antipsychotic Drugs and Their Side-Effects

1st Edition

Editors: Thomas Barnes
Hardcover ISBN: 9780120790357
eBook ISBN: 9781483288109
Imprint: Academic Press
Published Date: 8th November 1993
Page Count: 287
135.41 + applicable tax
54.95 + applicable tax
43.99 + applicable tax
72.95 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

Basic Science: B.E. Leonard, The Pharmacology of the Phenothiazines, Butyrophenones, Thioxanthines, and Diphenylbutylpiperidines. D.M. Coward, The Pharmacology of Clozapine-Like Atypical Antipsychotics. J. Gerlach, Pharmacology and Clinical Properties of Selective Dopamine Antagonists, with Focus on Substituted Benzamides. J.L. Waddington, Pre- and Postsynaptic D-1 to D-5 Dopamine Receptor Mechanisms in Relation to Antipsychotic Activity. N.J. Rupniak and S.D. Iversen, Prediction of Antipsychotic Activity. P.J. Harrison, Effects of Neuroleptics on Neuronal and Synaptic Structure. P.F. Liddle, Brain Imaging and Antipsychotic Drugs. S.H. Curry, Pharmacokinetics of Antipsychotic Drugs. Clinical Issues: S.R. Hirsch, The Assessment of Antipsychotic Activity in Clinical Trials. R.G. McCreadie, Indications of Antipsychotic Drugs. J.M. Kane, Acute Treatment. J.M. Davis, P.G. Janicak, A. Singla, and R.P. Sharma, Maintenance Treatment. D.A.W. Johnson, Depot Neuroleptics. T.R.E. Barnes and J.G. Edwards, The Side Effects of Antipsychotic Drugs I: Neuropsychiatric Effects. J.G. Edwards and T.R.E. Barnes, The Side Effects of Antipsychotic Drugs II: Effects on Other Physiological Systems.

Description

In line with other volumes in the Neuroscience Perspectives Series, this volume covers the background, pharmacology, molecular biology, and biochemistry of antipsychotic drugs, together with an overview assessment of the therapeutic considerations. Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including motor side-effects like parkinsonism. Studies show that lowering doses may still produce the antipsychotic effect while lessening the risk of side-effects. As all available antispychotic drugs are able to block dopamine, specifically D2 receptors, doses below the threshold level for producing acute motor disorder can still be therapeutically effective. With the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with better side-effect potential has arisen. Other novel antipsychotic agents include D1 receptor blockers, partial dopamine agonists and non-dopamine drugs such as 5-HT receptor blockers, sigma receptor antagonists and NMDA receptor agonists. This volume reviews both the basic science of the conventional and atypical neuroleptics and their present and potential therapeutic use.

Readership

Basic and clinical researchers in neuro- and psychopharmacology and neurosciences from academia and the pharmaceutical industry. May also be of interest to students in these fields.


Details

No. of pages:
287
Language:
English
Copyright:
© Academic Press 1993
Published:
Imprint:
Academic Press
eBook ISBN:
9781483288109
Hardcover ISBN:
9780120790357

About the Editors

Thomas Barnes Editor

Affiliations and Expertise

Charing Cross and Westminster Medical School, London, U.K.